Molecular marker analysis of SWOG S0636, a phase II trial of erlotinib and bevacizumab in never-smokers with advanced NSCLC.
Philip C. Mack
No relevant relationships to disclose
James Moon
No relevant relationships to disclose
Howard Jack West
No relevant relationships to disclose
Wilbur A. Franklin
No relevant relationships to disclose
Marileila Varella-Garcia
Other Remuneration - Biomarker Patent
Murry W. Wynes
No relevant relationships to disclose
Antoinette J. Wozniak
Honoraria - Genentech
Research Funding - Genentech
Mary Weber Redman
No relevant relationships to disclose
Fred R. Hirsch
Consultant or Advisory Role - Genentech
Research Funding - OSI Pharmaceuticals
Other Remuneration - Biomarker Patent
David R. Gandara
Consultant or Advisory Role - Genentech
Research Funding - Genentech